The clinical investigations of results can correct the medical program
Medication sourcing and quality (25%)
Early haematological response begins with reticulocytosis (increased production of immature red blood cells) typically by day 3-4 of treatment , particularly with injectable forms, though the full resolution of symptoms may take several weeks to months
Most of what we know comes from lab cells and tissue models, not large, longterm human studies, so this use case should be seen as an experiment, not a guarantee
According to Sikiric, PLIVA scientists were ready to move forward with a Phase 3 trial, in addition to new trials to test the effect of the peptide on wound healing
The information presented here is based primarily on preclinical (animal) research and clinical observation, and shouldn't be used as a substitute for professional medical guidance